![]() ![]() | Gonne, E., Goffinet, L., Geraerts, A., LEBEAU, A., Pleyers, C., Seidel, L., Pauwen, S., Darimont, C., Meuris, F., PIRON, M., Kakkos, A., Schoenen, S., Goffin, F., Delbecque, K., Lovinfosse, P., Danthine, D., Kridelka, F., & Gennigens, C. (February 2025). Survival Of Patients Over 70 Years Old With Locally Advanced Cervical Cancer : A Retrospective Analysis. International Journal of Gynecological Cancer, 35 (2), 100518. doi:10.1016/j.ijgc.2024.100518 |
![]() ![]() | Geraerts, A., Goffinet, L., LEBEAU, A., Darimont, C., Meuris, F., Pauwen, S., Delbecque, K., Gonne, E., Goffin, F., Seidel, L., Lovinfosse, P., Danthine, D., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2025). Correlation Between Hematological Parameters And Outcome In Patients With Locally Advanced Cervical Cancer Treated By Concomitant Chemoradiotherapy Followed By Brachytherapy. International Journal of Gynecological Cancer, 35 (2), 100527. doi:10.1016/j.ijgc.2024.100527 |
![]() ![]() | SZYKULA, C., Closon, F., de Landsheere, L., Goffin, F., Jason, M., Nervo, P., Kakkos, A., Nisolle, M., Kridelka, F., & Schoenen, S. (February 2025). Prise en charge des grossesses ectopiques par méthorexate. Étude rétrospective et revue de la littérature. Revue Médicale de Liège, 80 (2), 109 - 115. ![]() |
![]() ![]() | LEBEAU, A., Goffinet, L., Geraerts, A., Pleyers, C., Gonne, E., Seidel, L., Pauwen, S., Darimont, C., Meuris, F., PIRON, M., Kakkos, A., Schoenen, S., Goffin, F., Delbecque, K., Lovinfosse, P., Danthine, D., Kridelka, F., & Gennigens, C. (2025). Analysis Of Tumour Characteristics Associated With Visceral Recurrence In Locally Advanced Cervical Cancer. International Journal of Gynecological Cancer. doi:10.1016/j.ijgc.2024.100501 |
![]() ![]() | Goffinet, L., Geraerts, A., LEBEAU, A., Seidel, L., Darimont, C., Meuris, F., Pauwen, S., Delbecque, K., Gonne, E., Goffin, F., Lovinfosse, P., Danthine, D., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2025). Impact Of Lymph Node Assessment On Survival Outcomes In Locally Advanced Cervical Cancer : A Retrospective Study. International Journal of Gynecological Cancer, 35 (2), 100547. doi:10.1016/j.ijgc.2024.100547 |
![]() ![]() | DHEUR, A., Kakkos, A., Danthine, D., Delbecque, K., Goffin, F., Gonne, E., Lovinfosse, P., Pleyers, C., THILLE, A., Kridelka, F., & Gennigens, C. (11 November 2024). Lymph node assessment in cervical cancer: current approaches. Frontiers in Oncology, 14. doi:10.3389/fonc.2024.1435532 ![]() |
![]() ![]() | LEBEAU, A., Lenom, M., LAPAILLE, L., Gonne, E., PIRON, M., Goffin, F., Kakkos, A., Schoenen, S., Delbecque, K., PLEYERS, C., Seidel, L., Lovinfosse, P., Danthine, D., Kridelka, F., & Gennigens, C. (2024). EV286/#550 Hormone receptors expression in high-grade epithelial ovarian cancers: a retrospective study. International Journal of Gynecological Cancer, 232.1-A232. doi:10.1136/ijgc-2024-igcs.405 |
![]() ![]() | LAPAILLE, L., Lenom, M., Gonne, E., PIRON, M., Goffin, F., Kakkos, A., Schoenen, S., Kridelka, F., Delbecque, K., PLEYERS, C., Seidel, L., Lovinfosse, P., Danthine, D., LEBEAU, A., & Gennigens, C. (2024). EV285/#587 Neoadjuvant versus adjuvant chemotherapy in high-grade epithelial ovarian cancer: a retrospective study. International Journal of Gynecological Cancer, 231.3-A232. doi:10.1136/ijgc-2024-igcs.404 |
![]() ![]() | Salmon, A.* , LEBEAU, A.* , Streel, S., Dheur, A., Schoenen, S., Goffin, F., Gonne, E., Kridelka, F., Kakkos, A.* , & Gennigens, C.*. (22 June 2024). Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer Treatment Reviews, 129, 102790. doi:10.1016/j.ctrv.2024.102790 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Baccus, L., Dheur, A., Salmon, A., Delbecque, K., Goffin, F., De Cuypere, M., PLEYERS, C., Lovinfosse, P., Danthine, D., THILLE, A., Gonne, E., Gennigens, C., Kridelka, F., & Kakkos, A. (2024). 414 Potential association between quantified LVSI status and molecular profile in predicting nodal metastases for patient suffering early-stage endometrial cancer. International Journal of Gynecological Cancer, 34, 177-A178. ![]() |
![]() ![]() | DEMARTEAU, C., PLEYERS, C., HERMESSE, J., Gennigens, C., Kakkos, A., Gonne, E., Goffin, F., & Kridelka, F. (September 2023). #749 Optimizing brachytherapy applicators implantation in locally advanced cervical cancer with transrectal ultrasound guidance. International Journal of Gynecological Cancer, 33, 91-A92. doi:10.1136/ijgc-2023-esgo.183 ![]() |
![]() ![]() | Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866 ![]() * These authors have contributed equally to this work. |
![]() ![]() | DHEUR, A., Salmon, A., Streel, S., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (February 2023). p53 status : a strong negative prognostic factor in endometrial carcinoma [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. ![]() |
![]() ![]() | Salmon, A., Streel, S., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2023). Agreement between immunohistochemistry and molecular techniques to assess microsatellite instability and p53 status in endometrial cancer [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. ![]() |
![]() ![]() | Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203 ![]() |
![]() ![]() | Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264 ![]() |
![]() ![]() | DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States. ![]() |
![]() ![]() | Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States. ![]() |
![]() ![]() | De Cuypere, M., PLEYERS, C., HERMESSE, J., Lovinfosse, P., Delbecque, K., Gonne, E., Kakkos, A., Goffin, F., Kridelka, F., & Gennigens, C. (2022). A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study [Poster presentation]. 23rd European Congress on Gynecological Oncology, Berlin, Germany. ![]() |
![]() ![]() | Gennigens, C., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., Seidel, L., Streel, S., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Salmon, A. (2022). 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular analysis ? International Journal of Gynecological Cancer. doi:10.1136/ijgc-2022-ESGO.266 ![]() |
![]() ![]() | Daix, M., Angeles, M. A., Migliorelli, F., Kakkos, A., Martinez Gomez, C., Delbecque, K., Mery, E., Tock, S., Gabiache, E., De Cuypere, M., Goffin, F., Martinez, A., Ferron, G., & Kridelka, F. (July 2021). Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer. Journal of Gynecologic Oncology, 32 (4), 48. doi:10.3802/jgo.2021.32.e48 ![]() |
![]() ![]() | Kakkos, A., Ver Eecke, C., ONGARO, S., Traen, K., Peeters, F., Van Trappen, P., Laenen, A., Despierre, E., Van Nieuwenhuysen, E., Vergote, I., & Goffin, F. (May 2021). Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. European Journal of Surgical Oncology, 47 (5), 1117 - 1123. doi:10.1016/j.ejso.2020.10.005 ![]() |
![]() ![]() | LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514. ![]() |
![]() ![]() | GENNIGENS, C., KRIDELKA, F., JERUSALEM, G., SEIDEL, L., GOFFIN, F., Barbeaux, A., Forget, F., KAKKOS, A., HERMESSE, J., GONNE, E., & DE CUYPERE, M. (2019). Lymphocytes count at diagnosis is a potential survival predictor in patients treated by chemoradiation in locally advanced cervical cancer [Poster presentation]. ESGO 2019 Athens: 21st European Gynaecological Oncology Congress 2019, Athens, Greece. |
![]() ![]() | KAKKOS, A., GONNE, E., COIMBRA MARQUES, C., NERVO, P., REMACLE, G., THILLE, A., HAYETTE, M.-P., VAN LINTHOUT, C., KRIDELKA, F., & DELBECQUE, K. (2017). Le cas clinique du mois. Actinomycose pelvienne pseudo-tumorale : il fallait y penser. Revue Médicale de Liège, 72 (1), 10-13. ![]() |
KRIDELKA, F., GOFFIN, F., Leblanc, E., DE CUYPERE, M., DOYEN, J., DELBECQUE, K., KAKKOS, A., & THILLE, A. (2015). Laparoscopy and endometrial cancer. In Minimally Invasive surgery. G Smith. |
![]() ![]() | Doupagne, A., DE CUYPERE, M., KRIDELKA, F., GOFFIN, F., DELBECQUE, K., GENNIGENS, C., LAKOSI, F., KAKKOS, A., & HERMESSE, J. (September 2014). Parametrial boost does not replace optimal BT treatment in 102 patients with locally advanced cervical cancer (LACC) [Paper presentation]. ESGO, Torino, Italy. |